首页> 美国卫生研究院文献>The Primary Care Companion for CNS Disorders >Prevalence of Substance Misuse in New Patients in an Outpatient Psychiatry Clinic Using a Prescription Monitoring Program
【2h】

Prevalence of Substance Misuse in New Patients in an Outpatient Psychiatry Clinic Using a Prescription Monitoring Program

机译:使用处方监测程序在门诊精神病学诊所的新患者中滥用药物的情况

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

>Objective: To investigate the value of a prescription monitoring program in identifying prescription drug misuse among patients presenting to a resident physician outpatient psychiatry clinic at an academic medical center.>Method: Participants were 314 new patients aged 18 years or older presenting to the clinic from October 2011 to June 2012. Resident physicians completed a data collection form for each participant using information from the patient interview and from the prescription monitoring program report. Prescription drug misuse was defined as having any 1 of the following 5 criteria in the prescription monitoring program report: (1) filled prescriptions for 2 or more controlled substances, (2) obtained prescriptions from 2 or more providers, (3) obtained early refills, (4) used 3 or more pharmacies, and (5) the prescription monitoring program report conflicted with the patient’s report.>Results: At least 1 indicator of prescription drug misuse was found in 41.7% of patients. Over 69% of the patients that the residents believed were misusing prescription drugs actually met 1 of the criteria for prescription drug misuse. The prescription monitoring program report changed the management only 2.2% of the time. Patients with prior benzodiazepine use (χ21 = 17.68, P < .001), prior opioid use (χ21 = 19.98, P < .001), a personality disorder (χ21 = 7.22, P < .001), and chronic pain (χ21 = 14.31, P < .001) had a higher percentage of prescription drug misuse compared to patients without these factors.>Conclusion: Using the prescription monitoring program to screen patients with prior benzodiazepine and opioid use, with a personality disorder, and/or with chronic pain may be useful in confirming the suspicion of prescription drug misuse identified at the initial evaluation.
机译:>目的::调查处方监控程序对在学术医学中心就诊的住院医师门诊精神病诊所就诊的患者中识别处方药滥用的价值。>方法:从2011年10月到2012年6月,有314名18岁以上的新患者到诊所就诊。住院医师使用来自患者访谈和处方监测计划报告中的信息,为每个参与者填写了数据收集表。处方药滥用被定义为在处方监测计划报告中具有以下5个标准中的任何1个:(1)填充了2种或更多种受控物质的处方,(2)从2种或多种提供者处获得的处方,(3)获得了早期补充,(4)使用了3家或以上的药房,以及(5)处方监测程序报告与患者报告相冲突。>结果:在41.7%的患者中发现至少1种处方药物滥用指标。居民认为滥用处方药的患者中,有超过69%实际上符合处方药滥用的标准之一。处方监测计划报告仅2.2%的时间更改了管理层。曾使用苯二氮卓类药物的患者(χ 2 1 = 17.68,P <.001),曾使用过阿片类药物的患者(χ 2 1 = 19.98,P <.001),有个性疾病(χ 2 1 = 7.22,P <.001)和慢性疼痛(χ 2 1 = 14.31,P <.001)的处方药百分比较高与没有这些因素的患者相比误用。>结论:使用处方监测程序来筛查先前曾使用过苯二氮卓类药物和阿片类药物,人格障碍和/或患有慢性疼痛的患者,可能有助于确认怀疑初步评估中发现的处方药滥用情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号